Literature DB >> 22340974

Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011.

A Linde1, A Ternhag, A Torner, Be Claesson.   

Abstract

Swedish laboratories reported an increase of Mycoplasma pneumoniae during the autumn 2011. Data from the laboratory in Skövde, covering 12.9% of the Swedish population, indicate an approximate increase in the number of laboratory-confirmed cases in the whole country, from around 3,500 in 2009 to 11,100 in 2011. Antibiotics are recommended only for pneumonia, not bronchitis, but compared with the autumn 2009, 42,652 more prescriptions of doxycycline and macrolides were registered in the autumn 2011.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22340974

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  9 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  A multisite SNP genotyping and macrolide susceptibility gene method for Mycoplasma pneumoniae based on MALDI-TOF MS.

Authors:  Fei Zhao; Jianzhong Zhang; Xuemei Wang; Liyong Liu; Jie Gong; Zhixiang Zhai; Lihua He; Fanliang Meng; Di Xiao
Journal:  iScience       Date:  2021-04-16

3.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Authors:  Naoyuki Miyashita; Yasuhiro Kawai; Hiroto Akaike; Kazunobu Ouchi; Toshikiyo Hayashi; Takeyuki Kurihara; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

4.  Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?

Authors:  H S Blix; D F Vestrheim; V Hjellvik; D Skaare; A Christensen; M Steinbakk
Journal:  Epidemiol Infect       Date:  2014-11-12       Impact factor: 2.451

5.  Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.

Authors:  Roger Dumke; Christiane Schnee; Mathias W Pletz; Jan Rupp; Enno Jacobs; Konrad Sachse; Gernot Rohde
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

6.  Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective.

Authors:  Rebecca J Brown; Patrick Nguipdop-Djomo; Hongxin Zhao; Elaine Stanford; O Brad Spiller; Victoria J Chalker
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

7.  Molecular Typing of Mycoplasma pneumoniae Strains in Sweden from 1996 to 2017 and the Emergence of a New P1 Cytadhesin Gene, Variant 2e.

Authors:  Karolina Gullsby; Björn Olsen; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

8.  Trends in Antibiotic Use in Danish, Finnish, Norwegian and Swedish Children.

Authors:  Nils Skajaa; Lise Gehrt; Heta Nieminen; Ida Laake; Hélène Englund; Ute Wolff Sönksen; Berit Feiring; Christine Stabell Benn; Lill Trogstad; Arto A Palmu; Signe Sørup
Journal:  Clin Epidemiol       Date:  2022-08-07       Impact factor: 5.814

9.  No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.

Authors:  Karolina Gullsby; Kåre Bondeson
Journal:  Infect Ecol Epidemiol       Date:  2016-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.